Literature DB >> 953602

Oral contraceptive use in older women and fatal myocardial infarction.

J I Mann, W H Inman, M Thorogood.   

Abstract

A previous study of women who had died from myocardial infarction and of a control group of women matched with them for age suggested a fivefold increase in the risk of death from myocardial infarction among users of oral contraceptive aged 40-44 years compared with women not using such preparations. Only a small proportion of women in the infarction and control groups had used oral contraceptives, however, so the margin of error was wide. We therefore investigated a further 54 women in this age group who died from myocardial infarction and compared their oral contraceptive histories with those of age-matched, living controls. Combination of the findings from the present investigation with the previous results have enabled a revised estimate of a threefold increase in risk to be made. Although this risk estimate is similar to that previously shown for a younger age group, the total mortality attributable to complications associated with the use of oral contraceptives remained considerably greater among women over the age of 40.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953602      PMCID: PMC1687562          DOI: 10.1136/bmj.2.6033.445

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Oral contraceptives and death from myocardial infarction.

Authors:  J I Mann; W H Inman
Journal:  Br Med J       Date:  1975-05-03

2.  Thrombosis with low-estrogen oral contraceptives.

Authors:  P D Stolley; J A Tonascia; M S Tockman; P E Sartwell; A H Rutledge; M P Jacobs
Journal:  Am J Epidemiol       Date:  1975-09       Impact factor: 4.897

3.  Editorial: Hormone use to change normal physiology - is the risk worth it?

Authors:  D M Small
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

Review 4.  Effectiveness and risks of birth-control methods.

Authors:  D M Potts; G I Swyer
Journal:  Br Med Bull       Date:  1970-01       Impact factor: 4.291

5.  Estimation of relative risk from individually matched series.

Authors:  O S Miettinen
Journal:  Biometrics       Date:  1970-03       Impact factor: 2.571

  5 in total
  17 in total

Review 1.  Benefits and risks of third-generation oral contraceptives.

Authors:  E S Leblanc; A Laws
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London.

Authors:  J Slack; N Noble; T W Meade; W R North
Journal:  Br Med J       Date:  1977-08-06

3.  Trends in the content and use of oral contraceptives in the United States, 1964-88.

Authors:  B B Gerstman; T P Gross; D L Kennedy; R C Bennett; D K Tomita; B V Stadel
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

4.  The care of oral contraceptive users by general practitioners in Oxfordshire.

Authors:  B Johnson; M Thorogood
Journal:  J R Coll Gen Pract       Date:  1977-06

Review 5.  [Desogestrel contraceptives: the perfect pill for lipids?].

Authors:  L Laurendeau
Journal:  Can Fam Physician       Date:  1996-01       Impact factor: 3.275

Review 6.  Hormonal steroid contraceptives: a further review of adverse reactions.

Authors:  E G McQueen
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

7.  [Complications and late sequelae of contraception including sterilization (proceedings)].

Authors:  J Hammerstein
Journal:  Arch Gynakol       Date:  1977-07-29

8.  The case-control study and retrospective controls.

Authors:  J I Mann; M P Vessey
Journal:  Br Med J       Date:  1979-12-08

9.  [Morphology of acute coronary death in younger females].

Authors:  H Althoff
Journal:  Z Rechtsmed       Date:  1983

Review 10.  The relationship between oral contraceptive use, cancer and vascular disease.

Authors:  C La Vecchia; S Franceschi; P Bruzzi; F Parazzini; P Boyle
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.